NRx Pharmaceuticals, Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD · Warrants
0.0988
-0.0012 (-1.20%)
Jun 26, 2025, 4:00 PM - Market closed
-1.20%
Market Cap 60.51M
Revenue (ttm) n/a
Net Income (ttm) -24.11M
Shares Out 17.29M
EPS (ttm) -1.92
PE Ratio n/a
Forward PE 9.50
Dividend n/a
Ex-Dividend Date n/a
Volume 19,542
Open 0.0911
Previous Close 0.1000
Day's Range 0.0735 - 0.1000
52-Week Range 0.0395 - 0.5000
Beta 1.55
Analysts n/a
Price Target n/a
Earnings Date Mar 28, 2025

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country United States
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Full Company Profile

News

There is no news available yet.